Evaluating the effectiveness of GAAD for early detection of hepatocellular carcinoma Post author: Post published:October 25, 2024 Post category:uncategorized Early detection of hepatocellular carcinoma (HCC) is crucial for improving survival in patients with chronic hepatitis. You Might Also Like Study finds increased liver cancer risk among Mexican Americans in subsequent generations November 20, 2023 Harnessing the power of miRNA for cancer diagnosis and treatment October 15, 2024 Metabolomic biomarkers improve diabetes risk prediction accuracy December 12, 2024
Study finds increased liver cancer risk among Mexican Americans in subsequent generations November 20, 2023